Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 443953Generated: October 23, 2026

Erythromycin ethyl succinate

Esinol · Evesin · Refkas · Anamycin · Arpimycin · E-Mycin e · Eryliquid · Monomycin

https://huagongshe.com/en/chemical/443953

Erythromycin ethyl succinate molecular structure

Identifiers & Physical Properties

CAS No.1264-62-6
Molecular formulaC43H75NO16
Average molar mass862.1 g/mol
Monoisotopic mass861.50858532 g/mol
SMILESCCOC(=O)CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C
InChIKeyNSYZCCDSJNWWJL-YXOIYICCSA-N
PubChem CID443953
ChEMBLCHEMBL1200688
ChEBICHEBI:31555
EC No.215-033-8
DTXSIDDTXSID4022993

Chemical & Physical Properties

XLogP3.4
Topological polar surface area226
Hydrogen bond donors4
Hydrogen bond acceptors17
Rotatable bonds14
Heavy atoms60
Formal charge0
Complexity1,450
DrugsPharmaceuticals -> Antibiotics
LipidsPolyketides [PK] -> Ansamycins and related polyketides [PK05]
OdorODORLESS OR PRACTICALLY SO
TastePRACTICALLY TASTELESS
Color/FormWHITE OR SLIGHTLY YELLOW, CRYSTALLINE POWDER
SolubilityFREELY SOL IN ACETONE & CHLOROFORMSOL IN 95% ETHANOL & BENZENESPARINGLY SOL IN ETHERVERY SLIGHTLY SOL IN WATERFREELY SOLUBLE IN ALC, SOL IN POLYETHYLENE GLYCOLethanol: soluble50mg/mLFreely soluble in organic solvents, practically insoluble in water
Human DrugsFDA approved drugs -> Active ingredient
Refractive indexINDEX OF REFRACTION: 1.490 (ALPHA), 1.515 (BETA), 1.567 (GAMMA)1.5280 (estimate)
Stability/Shelf LifeAFTER RECONSTITUTION OF COMMERCIALLY AVAILABLE POWDER, SUSPENSIONS ARE STABLE FOR 10 DAYS @ 2-8 °CCOMMERCIALLY AVAILABLE TABLETS & POWDER FOR ORAL SUSPENSION HAVE EXPIRATION DATES OF 2 YR FOLLOWING DATES OF MANUFACTURECOMMERCIALLY AVAILABLE SUSPENSIONS HAVE EXPIRATION DATES OF 18 MONTHS FOLLOWING DATES OF MANUFACTUREERYTHROMYCIN ETHYLSUCCINATE IM INJECTION HAS AN EXPIRATION DATE OF 18 MONTHS FOLLOWING DATE OF MFR
Dissociation ConstantsPKA 7.1
Collision Cross Section257.7 Ų [M+H]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards]
Melting point219-224 C
Boiling point778.19°C (rough estimate)
Density1.1417 (rough estimate)
Flash point>110°(230°F)
Storage conditionsSealed in dry,Room Temperature
Physical statesolid
pKa (acidity coefficient)13.09±0.70(Predicted)
Colorwhite
StabilityHygroscopic
Major applicationspharmaceuticalpharmaceutical small molecule
InChIKeyNSYZCCDSJNWWJL-UHFFFAOYSA-N
SMILESC1(OC(=O)CCC(OCC)=O)C(N(C)C)CC(C)OC1OC1C(CC(C(C(C(O)C(O)(C)C(CC)OC(=O)C(C)C(OC2OC(C)C(O)C(C)(OC)C2)C1C)C)=O)C)(O)C
CAS DataBase Reference1264-62-6
EWG's Food Scores1
FDA UNII1014KSJ86F
UNSPSC Code41116107
NACRESNA.24
GHS pictogramGHS08
Signal wordDanger
GHS hazard statementsH317-H334
GHS precautionary statementsP261-P280-P284-P304+P340-P342+P311
Hazard symbolsXn,Xi
Risk statements (R)42/43-36/37/38
Safety statements (S)36-26
Water hazard class (WGK)2
RTECS numberWM9800000
Customs code29419000
Storage class11 - Combustible Solids
Hazard classResp. Sens. 1Skin Sens. 1
Hazardous substances data1264-62-6(Hazardous Substances Data)
ToxicityLD50 oral in mouse: > 10gm/kg

Safety & Regulations

GHS classificationDangerH317 (29.9%): May cause an allergic skin reaction [Warning Sensitization, Skin]P233, P260, P261, P264+P265, P271, P272, P280, P284, P302+P352, P304+P340, P305+P351+P338, P321, P333+P317, P337+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 144 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Other safety informationIMAP assessments - Erythromycin, 2'-(ethyl butanedioate): Environment tier I assessment
Hazard Classes and CategoriesSkin Sens. 1 (29.9%)
Human Toxicity ExcerptsAMONG HYPERSENSITIVITY REACTIONS ARE FEVER, EOSINOPHILIA, & SKIN ERUPTIONS, EACH OF WHICH MAY OCCUR ALONE OR IN COMBINATIONTHEY DISAPPEAR SHORTLY AFTER THERAPY IS STOPPED. ...MAY PRODUCE IRRITATIVE EFFECTS. ORAL ADMIN...FREQUENTLY ACCOMPANIED BY EPIGASTRIC DISTRESS, WHICH MAY BE QUITE SEVERE. /ERYTHROMYCIN/IM INJECTION OF QUANTITIES LARGER THAN 100 MG PRODUCES...SEVERE PAIN... PERSISTS FOR HR: IV PERFUSIONS OF 1-G DOSES...ALMOST REGULARLY IS FOLLOWED BY THROMBOPHLEBITIS. ...6 PT...DEVELOPED DIFFICULTY IN HEARING WHILE BEING TREATED WITH 4 G/DAY...IV. ... CESSATION...LED TO COMPLETE RETURN OF NORMAL HEARING... /ERYTHROMYCIN/A CASE REPORT OF HEPATOTOXICITY RESULTING FROM ERYTHROMYCIN ETHYLSUCCINATE THERAPY IN 60-YR-OLD FEMALE IS DESCIRBED.
Water hazard class (WGK)2
RTECS numberWM9800000
Customs code29419000
ToxicityLD50 oral in mouse: > 10gm/kg
Risk statements (R)42/43-36/37/38
Signal wordDanger
GHS pictogramGHS08
Hazard symbolsXn,Xi
Safety statements (S)36-26
Storage class11 - Combustible Solids
GHS hazard statementsH317-H334
Hazard classResp. Sens. 1Skin Sens. 1
GHS precautionary statementsP261-P280-P284-P304+P340-P342+P311
Hazardous substances data1264-62-6(Hazardous Substances Data)

Applications & Uses

Uses

A broad spectrum antibiotic commonly targeting bacteria responsible for respiratory tract infections

General Description

Erythromycin ethylsuccinate (EES, Pediamycin, EryPed) isthe ethylsuccinate mixed ester of erythromycin in which the2'-hydroxyl group of the desosamine is esterified. It isabsorbed as the ester and hydrolyzed slowly in the body toform erythromycin. It is somewhat acid labile, and itsabsorption is enhanced by the presence of food. The ester isinsoluble in water but soluble in alcohol and ether.